Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 3050 of 3173 entries
View as:

Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021

Phase: N/A Priority: Normal
NCT ID: NCT02342548 Org: User:
Start: 02/25/15 End: 02/06/17 Due: 02/06/18

Healthy Volunteers Study to Estimate the Effects of Food on the Bioavailability of Oxycodone and Naltrexone/6- Β -Naltrexol From a Extended Release Formulation of Oxycodone With Sequestered Naltrexone

Phase: N/A Priority: Normal
NCT ID: NCT01456507 Org: User:
Start: 10/31/11 End: 01/31/12 Due: 01/31/13

Prospective Multicenter Doubleblind Randomized Study of NXL104/Ceftazidime + Metronidazole vs. Meropenem in Treatment of Complicated Intra-abdominal Infections

Phase: N/A Priority: Normal
NCT ID: NCT00752219 Org: User:
Start: 03/31/09 End: 12/31/09 Due: 12/31/10

PK and Bioavailability Comparison of Tofacitinib Between a Modified Release and The Immediate Release Formulation

Phase: N/A Priority: Normal
NCT ID: NCT04403776 Org: User:
Start: 12/03/18 End: 02/12/19 Due: 02/12/20

A Study to Assess Two Forms of The Study Medicine (Ritlecitinib) in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT05852340 Org: User:
Start: 05/09/23 End: 07/24/23 Due: 07/24/24

Infliximab Biosimilar "Pfizer" Drug Use Investigation (Crohn's Disease or Ulcerative Colitis)

Phase: N/A Priority: Normal
NCT ID: NCT03884439 Org: User:
Start: 03/18/19 End: 02/02/24 Due: 02/02/25

Palbociclib Pharmacokinetics Study In Postmenopausal Chinese Women With ER (+), HER2 (-) Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02499146 Org: User:
Start: 09/11/15 End: 12/31/24 Due: 12/31/25

Assessment of Efficacy and Safety of UK-390,957 in Men With Premature Ejaculation

Phase: N/A Priority: Normal
NCT ID: NCT00143117 Org: User:
Start: 08/31/04 End: 06/30/05 Due: 06/30/06

Serotype Distribution of Chest X-ray Confirmed Pneumococcal Community Acquired Pneumonia in the Adult Population in Greece, Over 1 Year.

Phase: N/A Priority: Normal
NCT ID: NCT01564771 Org: User:
Start: 01/31/11 End: 04/30/13 Due: 04/30/14

A 14-week, Multi-center Study of [S,S]-Reboxetine in Patients With Fibromyalgia.

Phase: N/A Priority: Normal
NCT ID: NCT00612170 Org: User:
Start: 12/31/07 End: 05/31/09 Due: 05/31/10

A First-in-human Study of Single Doses of PF-07328948 Which is Given to Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT05654181 Org: User:
Start: 10/17/22 End: 05/03/23 Due: 05/03/24

Long-Term Open-Label, Safety Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients

Phase: N/A Priority: Normal
NCT ID: NCT01210443 Org: User:
Start: 11/30/10 End: 12/31/10 Due: 12/31/11

Dose-Escalating Multiple Dose Study of PD-0360324 in Combination With Methotrexate in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00550355 Org: User:
Start: 08/31/07 End: 06/30/09 Due: 06/30/10

A Preliminary Study to Evaluate PF-07264660 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05496738 Org: User:
Start: 08/16/22 End: 05/06/24 Due: 05/06/25

A Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive Crises

Phase: N/A Priority: Normal
NCT ID: NCT04935879 Org: User:
Start: 10/04/21 End: 06/06/24 Due: 06/06/25

Study of BMN 673, a PARP Inhibitor, in Healthy Adult Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01776437 Org: User:
Start: 02/28/13 End: 07/31/13 Due: 07/31/14

Study to Evaluate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT03349060 Org: User:
Start: 12/07/17 End: 03/26/19 Due: 03/26/20

PF-06669571 In Subjects With Idiopathic Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02565628 Org: User:
Start: 11/16/15 End: 05/13/16 Due: 05/13/17

A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00051051 Org: User:
Start: 12/31/02 End: 05/31/05 Due: 05/31/06

CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First Relapse

Phase: N/A Priority: Normal
NCT ID: NCT00003673 Org: User:
Start: 03/31/98 End: 03/31/99 Due: 03/31/00

Long Term Extension Study Evaluating Safety, Tolerability and Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00955409 Org: User:
Start: 11/05/09 End: 12/17/13 Due: 12/17/14

Study Evaluating Inotuzumab Ozogamicin (CMC-544) In Indolent Non-Hodgkins Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00868608 Org: User:
Start: 07/30/09 End: 06/27/13 Due: 06/27/14

A Multiple Dose Study Of PF-05161704 In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01202266 Org: User:
Start: 08/31/10 End: 12/31/10 Due: 12/31/11

A Research Study To Test How Multiple Doses Of Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given by Subcutaneous Injection (SC) (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen)

Phase: N/A Priority: Normal
NCT ID: NCT02766634 Org: User:
Start: 03/31/16 End: 06/30/16 Due: 06/30/17

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06952660 Org: User:
Start: 05/07/25 End: 12/13/28 Due: 12/13/29